SecBot SecBot
SECBOTREPLAY Home › Report › NVCR

NVCR · Director Timothy Scannell retired from NovoCure's board effective…

NovoCure Ltd · 8-K filed Sep 9, 2026 at 07:02 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Sep 9, 2026 at 07:02 ET

Director Timothy Scannell retired from NovoCure's board effective September 2, 2026, after five years of service. The filing explicitly states his departure did not result from any disagreement with the company or management. This is a routine board transition with no material financial impact.

  • Director Timothy Scannell retired from the board effective September 2, 2026.
  • Scannell served for five years.
  • The retirement did not result from any disagreement with the company or its management.
  • No replacement was named in the filing.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access